206 related articles for article (PubMed ID: 29991502)
1. Remission of Spontaneous Canine Tumors after Systemic Cellular Viroimmunotherapy.
Cejalvo T; Perisé-Barrios AJ; Del Portillo I; Laborda E; Rodriguez-Milla MA; Cubillo I; Vázquez F; Sardón D; Ramirez M; Alemany R; Del Castillo N; García-Castro J
Cancer Res; 2018 Sep; 78(17):4891-4901. PubMed ID: 29991502
[TBL] [Abstract][Full Text] [Related]
2. Systemic cellular viroimmunotherapy for canine high-grade gliomas.
Cloquell A; Mateo I; Gambera S; Pumarola M; Alemany R; García-Castro J; Perisé-Barrios AJ
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600663
[TBL] [Abstract][Full Text] [Related]
3. AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses.
Rodríguez-Milla MÁ; Morales-Molina A; Perisé-Barrios AJ; Cejalvo T; García-Castro J
Cancer Gene Ther; 2021 Feb; 28(1-2):64-73. PubMed ID: 32457488
[TBL] [Abstract][Full Text] [Related]
4. Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer.
Naik S; Galyon GD; Jenks NJ; Steele MB; Miller AC; Allstadt SD; Suksanpaisan L; Peng KW; Federspiel MJ; Russell SJ; LeBlanc AK
Mol Cancer Ther; 2018 Jan; 17(1):316-326. PubMed ID: 29158470
[TBL] [Abstract][Full Text] [Related]
5. Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas.
Petrov I; Gentschev I; Vyalkova A; Elashry MI; Klymiuk MC; Arnhold S; Szalay AA
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664672
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks.
Arendt M; Nasir L; Morgan IM
Vet Comp Oncol; 2009 Sep; 7(3):153-61. PubMed ID: 19691644
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.
Patil SS; Gentschev I; Nolte I; Ogilvie G; Szalay AA
J Transl Med; 2012 Jan; 10():3. PubMed ID: 22216938
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy.
Adelfinger M; Bessler S; Frentzen A; Cecil A; Langbein-Laugwitz J; Gentschev I; Szalay AA
Viruses; 2015 Jul; 7(7):4075-92. PubMed ID: 26205404
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.
Hwang CC; Igase M; Sakurai M; Haraguchi T; Tani K; Itamoto K; Shimokawa T; Nakaichi M; Nemoto Y; Noguchi S; Coffey M; Okuda M; Mizuno T
Vet Comp Oncol; 2018 Jun; 16(2):229-238. PubMed ID: 29076241
[TBL] [Abstract][Full Text] [Related]
11. A potential bat adenovirus-based oncolytic virus targeting canine cancers.
Matsugo H; Kitamura-Kobayashi T; Kamiki H; Ishida H; Sekine W; Takenaka-Uema A; Nakagawa T; Murakami S; Horimoto T
Sci Rep; 2021 Aug; 11(1):16706. PubMed ID: 34408176
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses.
Hadryś A; Sochanik A; McFadden G; Jazowiecka-Rakus J
Eur J Pharmacol; 2020 May; 874():172991. PubMed ID: 32044323
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic virotherapy of canine and feline cancer.
Gentschev I; Patil SS; Petrov I; Cappello J; Adelfinger M; Szalay AA
Viruses; 2014 May; 6(5):2122-37. PubMed ID: 24841386
[TBL] [Abstract][Full Text] [Related]
14. To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses.
Cassady KA; Haworth KB; Jackson J; Markert JM; Cripe TP
Viruses; 2016 Feb; 8(2):. PubMed ID: 26861381
[TBL] [Abstract][Full Text] [Related]
15. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
Edukulla R; Woller N; Mundt B; Knocke S; Gürlevik E; Saborowski M; Malek N; Manns MP; Wirth T; Kühnel F; Kubicka S
Cancer Res; 2009 Feb; 69(4):1448-58. PubMed ID: 19190348
[TBL] [Abstract][Full Text] [Related]
16. Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene.
Urbasic AS; Hynes S; Somrak A; Contakos S; Rahman MM; Liu J; MacNeill AL
Am J Vet Res; 2012 Aug; 73(8):1252-61. PubMed ID: 22849686
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy.
Gómez A; Sardón D; Cejalvo T; Vázquez F; García-Castro J; Perisé-Barrios AJ
Mol Ther Oncolytics; 2020 Sep; 18():525-534. PubMed ID: 32995478
[TBL] [Abstract][Full Text] [Related]
18. Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager.
Wing A; Fajardo CA; Posey AD; Shaw C; Da T; Young RM; Alemany R; June CH; Guedan S
Cancer Immunol Res; 2018 May; 6(5):605-616. PubMed ID: 29588319
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Rincón E; Cejalvo T; Kanojia D; Alfranca A; Rodríguez-Milla MÁ; Gil Hoyos RA; Han Y; Zhang L; Alemany R; Lesniak MS; García-Castro J
Oncotarget; 2017 Jul; 8(28):45415-45431. PubMed ID: 28525366
[TBL] [Abstract][Full Text] [Related]
20. From virotherapy to oncolytic immunotherapy: where are we now?
Coffin RS
Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
